Galectin Therapeutics Inc. (NASDAQ:GALT) Investor Alert: Lawsuit Alleges False and Misleading Statements

San Diego, CA -- (SBWIRE) -- 08/11/2014 -- An investor, who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT), filed a lawsuit in the U.S. District Court for the District of Nevada over alleged violations of Federal Securities Laws by Galectin Therapeutics Inc. in connection with certain allegedly false and misleading statements made between January 6, 2014 and July 28, 2014.